The impairment of CD8 T cell response did not depend on the source of antigen, as it was observed with antigens of viral (HPV-E7 and VSV-GP) origin as well as tumor specific neoantigens (adpgk, reps-1, rpl-18), which exhibit a wide range of immunogenicity. The gene discussed is RPL18; the disease is neoplasm.